Sandoz: Novartis Plans To Close A Sandoz Plant In North Carolina, Well Being News, Et Healthworld
“We’re seeing a quite rapid launch uptake for this brand in the third-fourth line castrate-resistant, metastatic prostate cancer segment,” said Novartis CEO Vas Narasimhan in a...
